A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors. Mar 2009 - Cancer Ther; 6(B):1543-9143 [PMID:19129927] [Lepisto AJ] [Moser AJ] [Zeh H] [Lee K] [Bartlett D] [McKolanis JR] [Geller BA] [Schmotzer A] [Potter DP] [Whiteside T] [Finn OJ] [Ramanathan RK]
